Urinary Bladder, Overactive: Clinical Trials

10 trials for Urinary Bladder, Overactive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 4 unknown, 1 recruiting. 10 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 110Completed 5, Unknown 4, Recruiting 1

Follow Urinary Bladder, Overactive: new trials by email Literature Review of Urinary Bladder, Overactive trials Research Report on Urinary Bladder, Overactive

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Self-Start Triage Model for Post-Botox® Lower Urinary Tract Symptoms
Macrobid® Capsules 100 mg, Standard Medical Care (SMC) - Overactive Bladder
Early Phase 1RecruitingThe Cleveland Clinic2602026-07-312026-08-03
Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls
Pelvic Floor Muscle Training, Mirabegron, Trospium Chloride - Urinary Bladder, Overactive, Urinary Incontinence
Early Phase 1CompletedThe University of Texas Medical Branch, Galveston482023-09-282026-06-22
Safety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson's Disease
oral anti-Parkinson drugs and injection of botulinum toxin, oral anti-Parkinson's drugs - Parkinson's Disease, Overactive Bladder
Early Phase 1UnknownZhujiang Hospital602023-08-262023-08-18
Repetitive Transcranial Magnetic Stimulation in Women With Overactive Bladder With Urgency Incontinence
Repetitive Transcranial Magnetic Stimulation - Overactive Bladder, Urge Incontinence
Early Phase 1UnknownUniversity of Southern California102021-10-282021-11-17
Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder
Transvaginal botulinum toxin A (BTA) injection - Overactive Bladder, Bladder, Overactive
Early Phase 1CompletedStanford University152019-06-202022-07-19
Treatment of Spinal Cord Injury Patients for Neurogenic Bladder: Anticholinergic Agent vs. Mirabegron
Mirabegron - Spinal Cord Injuries, Neurogenic Bladder
Early Phase 1CompletedThe University of Texas Health Science Center at San Antonio202018-12-052021-06-22
Clinical Trial of Sacral Neuromodulation for Treatment of Refractory Overactive Bladder (OAB)
PINS SNS - Refractory Overactive Bladder
Early Phase 1UnknownBeijing Pins Medical Co., Ltd72015-10-012016-10-11
IVES for Treatment of UUI and OAB
EMED detruset(TM) intravesical electrical stimulation - Urinary Bladder, Overactive, Urinary Incontinence, Urge
Early Phase 1CompletedLoma Linda University172014-12-012017-01-04
Neurogenic Overactive Bladder Treatment on Parkinson's Disease Through Back Tibial Nerve Electrostimulation
Back Tibial Nerve Electrostimulation, Placebo Electrostimulation - Overactive Bladder, Parkinson Disease
Early Phase 1UnknownTatiane Gomes de Araujo302014-07-012015-10-22
Randomized, Double-Blinded, Placebo-Controlled Trial of Laxatives for Children With Urge Syndrome
MiraLAX, Placebos - Constipation
Early Phase 1CompletedUniversity of Texas Southwestern Medical Center1382007-12-102021-01-15

Narrower conditions

Urinary Incontinence, Urge (3)  ·  Parkinson Disease (2)  ·  Constipation (1)  ·  Spinal Cord Injuries (1)  ·  Urinary Bladder, Neurogenic (1)  ·  Urinary Incontinence (1)

Broader conditions

Female Urogenital Diseases (10)  ·  Female Urogenital Diseases and Pregnancy Complications (10)  ·  Lower Urinary Tract Symptoms (10)  ·  Male Urogenital Diseases (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Signs and Symptoms (10)  ·  Urinary Bladder Diseases (10)  ·  Urogenital Diseases (10)  ·  Urologic Diseases (10)  ·  Urological Manifestations (10)  ·  Urination Disorders (4)  ·  Central Nervous System Diseases (3)  ·  Nervous System Diseases (3)  ·  Urinary Incontinence (3)  ·  Basal Ganglia Diseases (2)

Interventions

mirabegron (2)  ·  Antiparkinson Agents (1)  ·  Glucose (1)  ·  Injections (1)  ·  Nitrofurantoin (1)  ·  Polyethylene Glycols (1)  ·  Transcranial Magnetic Stimulation (1)  ·  polyethylene glycol 3350 (1)  ·  trospium chloride (1)

Sponsors

Beijing Pins Medical Co., Ltd (1)  ·  Loma Linda University (1)  ·  Stanford University (1)  ·  Tatiane Gomes de Araujo (1)  ·  The Cleveland Clinic (1)  ·  The University of Texas Health Science Center at San Antonio (1)  ·  The University of Texas Medical Branch, Galveston (1)  ·  University of Southern California (1)  ·  University of Texas Southwestern Medical Center (1)  ·  Zhujiang Hospital (1)

Countries

United States (6)  ·  China (2)  ·  Brazil (1)

Top investigators

Amy D. Dobberfuhl, M.D. (1)  ·  Jose Geraldo Lopes Ramos (1)  ·  Larissa Rodriguez, MD (1)  ·  Michelle Trbovich, MD (1)  ·  Sam Siddighi, MD (1)  ·  Shannon Wallace, MD (1)  ·  Shuzhen Zhu, Doctor (1)  ·  Steve Fisher (1)  ·  Warren T Snodgrass, MD (1)

Results publications

PMID 33326648, PMID 34156506, PMID 35607890, PMID 38178267

NIH funding

R21AG081900 (1)